Fusion Pharmaceuticals Inc.
FUSN · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $62 | $44 | $53 | $91 |
| Short-Term Investments | $172 | $127 | $148 | $132 |
| Receivables | $4 | $2 | $0 | $1 |
| Inventory | $0 | -$10 | $0 | $4 |
| Other Curr. Assets | $5 | $1 | $0 | $1 |
| Total Curr. Assets | $243 | $179 | $212 | $228 |
| Property Plant & Equip (Net) | $24 | $10 | $9 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $15 | $16 | $20 | $77 |
| Tax Assets | $4 | $5 | $2 | $1 |
| Other NC Assets | $1 | $9 | $9 | $3 |
| Total NC Assets | $42 | $40 | $41 | $83 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $286 | $219 | $252 | $311 |
| Liabilities | – | – | – | – |
| Payables | $2 | $3 | $2 | $3 |
| Short-Term Debt | $4 | $1 | $1 | $0 |
| Tax Payable | $0 | $0 | $0 | $3 |
| Deferred Revenue | $0 | $1 | $2 | $1 |
| Other Curr. Liab. | $10 | $10 | $7 | $5 |
| Total Curr. Liab. | $16 | $15 | $13 | $12 |
| LT Debt | $35 | $39 | $6 | $0 |
| Deferred Rev, NC | $1 | $3 | $3 | $4 |
| Deferred Tax Liab, NC | $11 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $47 | $42 | $8 | $4 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $63 | $57 | $21 | $16 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$377 | -$282 | -$194 | -$113 |
| AOCI | $0 | -$0 | -$0 | $0 |
| Other Equity | $599 | $445 | $426 | $408 |
| Total Equity | $222 | $162 | $231 | $295 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $311 |
| Total Liab. & Tot. Equity | $286 | $219 | $252 | $311 |
| Net Debt | -$23 | -$4 | -$46 | -$91 |